TITLE

Screening for Prostate Cancer: EARLY DETECTION HELPS SAVE LIVES

PUB. DATE
December 2006
SOURCE
Urology Times;12/1/2006 Modern Health for Men Sup, Vol. 34, p7
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents the medical screening for prostate cancer, which is regarded as the second most common cause of death among men in the U.S. It is mentioned that screening tests can identify prostate cancer early. The screening tests include prostate-specific antigen blood tests and the digital rectal examination. However, when the treatments have abnormal results, men with prostate cancer need to undergo prostate needle biopsy or transrectal ultrasound.
ACCESSION #
23526965

 

Related Articles

  • Why do men refuse or attend population-based screening for prostate cancer? Nijs, H. G. T.; Essink-Bot, M. L.; DeKoning, H. J.; Kirkels, W. J.; Schröder, F. H. // Journal of Public Health Medicine;Sep2000, Vol. 22 Issue 3, p312 

    Background. The aims of this study were to investigate the motives for refusing or attending population-based screening for prostate cancer, in relation to various background characteristics.

  • Pathologic Features of Prostate Cancer Found at Population-Based Screening With a Four-Year Interval. Hoedemaeker, Robert F.; van der Kwast, Theodorus H.; Boer, Rob; de Koning, Harry J.; Roobol, Monique; Vis, André N.; Schröder, Fritz H. // JNCI: Journal of the National Cancer Institute;8/15/2001, Vol. 93 Issue 16, p1153 

    Examines the pathologic features of prostate cancer observed on a population based screening tests. Comparison on the pathology findings from needle biopsy cores conducted to the patients; Malignancy of the cancer prevalent in men; Interval of another screening test conducted.

  • Study recommends 4-year screening interval for PCa. Guttman, Cheryl // Urology Times;Nov2003, Vol. 31 Issue 11, p1 

    Reports on the findings of a medical study recommending at least a four-year interval in prostate cancer screening. Research on the sensitivity of initial screening and cancer rate interval during the initial four-year follow-up period after randomization; Consideration for prognostic factors;...

  • Prostate Cancer Early Detection Using PSA. Maria, C.; Nedelcuţă, C.; Pănus, A.; Drăgoescu, O.; Tomescu, P.; Bondari, A. // Acta Medica Marisiensis;Ago2010, Vol. 56 Issue 4, p403 

    Prostate cancer is a major health issue worldwide as it is the second most frequently diagnosed cancer in males after lung cancer. PSA (Prostate Specific Antigen) is the only screening marker for prostate cancer. Objectives: Retrospective analysis of the early prostate cancer diagnosis program...

  • Report from Durham. Moul, J. W. // Prostate Cancer & Prostatic Diseases;2005, Vol. 8 Issue 3, p201 

    Introduces several articles on prostate cancer research. Development of a risk progression model for benign prostatic hyperplasia (BPH); Application of complementary and alternative medicines for BPH; Medical screening technique for prostate cancer patients.

  • Comparison of narrow-band imaging and conventional nasopharyngoscopy for the screening of unaffected members of families with nasopharyngeal carcinoma. Ho, Ching-Yin; Chan, Kee-Tak; Chu, Pen-Yuan // European Archives of Oto-Rhino-Laryngology;Sep2013, Vol. 270 Issue 9, p2515 

    Familial aggregation of nasopharyngeal carcinoma (NPC) has been widely reported. The excess risk is about 4-8-fold among first-degree relatives of NPC patients compared with those without a family history of the disease. We used nasopharyngoscopy and a narrow-band image system (NBI) to screen...

  • Prostate Cancer: A Review of Common Underwriting Problems, Part 2. Richie, Rodney C.; Swanson, John O // Journal of Insurance Medicine;2004, Vol. 36 Issue 4, p310 

    This article is Part 2 of a two-part discussion of prostate cancer from an underwriting perspective that covers clinical staging, tissue staging, and follow-up of treated prostate cancer. Prostate biopsy is the diagnostic gold standard. Needle biopsy technique, sensitivity and specificity and...

  • Greater cancer survival rate linked to GP testing.  // GP: General Practitioner;1/28/2002, p7 

    Reports the results of a research on the link of prostate cancer survival to general practice testing in England. Increase in one- and five-year survival in patients diagnosed since 1993; Percentage chance of men diagnosed with prostate cancer of still being alive after five years; Link of the...

  • Screening for prostate cancer: Who and how often? Schwartz, Kendra; Deschere, Bruce; Jinping Xu // Journal of Family Practice;Jul2005, Vol. 54 Issue 7, p586 

    This article reviews the latest information relevant to the controversy regarding prostate cancer screening in asymptomatic men. The article offers "talking points" for family physicians to use when discussing screening with patients, and lists Web sites that patients may find helpful when...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics